Jill Giles‐Komar

1.7k total citations
30 papers, 1.3k citations indexed

About

Jill Giles‐Komar is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jill Giles‐Komar has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 15 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Molecular Biology. Recurrent topics in Jill Giles‐Komar's work include Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (7 papers) and Protein purification and stability (4 papers). Jill Giles‐Komar is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (15 papers), Glycosylation and Glycoproteins Research (7 papers) and Protein purification and stability (4 papers). Jill Giles‐Komar collaborates with scholars based in United States, Belgium and Iran. Jill Giles‐Komar's co-authors include Bernard J. Scallon, Eva Emmell, David J. Shealy, Jacqueline Benson, Mary Ann Mascelli, George A. Heavner, David Peritt, Anuk Das, A. Paige Davis Volk and Lily Li and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Jill Giles‐Komar

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Giles‐Komar United States 17 632 349 249 232 211 30 1.3k
Maryvonne Dueymes France 21 592 0.9× 288 0.8× 230 0.9× 340 1.5× 131 0.6× 60 1.5k
Liliane Fossati‐Jimack United Kingdom 27 1.6k 2.5× 448 1.3× 365 1.5× 215 0.9× 112 0.5× 65 2.1k
Eva Emmell United States 12 371 0.6× 297 0.9× 175 0.7× 215 0.9× 86 0.4× 18 1.0k
Almut Meyer‐Bahlburg Germany 19 1.4k 2.2× 249 0.7× 120 0.5× 110 0.5× 235 1.1× 41 1.9k
Alison M. Gizinski United States 7 986 1.6× 497 1.4× 137 0.6× 146 0.6× 107 0.5× 12 1.6k
Hirofumi Shoda Japan 23 1.1k 1.8× 450 1.3× 205 0.8× 168 0.7× 104 0.5× 100 2.0k
H. J. Radzun Germany 20 552 0.9× 405 1.2× 188 0.8× 127 0.5× 77 0.4× 51 1.5k
Pojen Chen United States 12 978 1.5× 462 1.3× 281 1.1× 94 0.4× 154 0.7× 14 1.7k
Jeanine Baisch United States 14 1.8k 2.8× 620 1.8× 206 0.8× 140 0.6× 425 2.0× 22 2.4k
Yoshinori Katada Japan 17 462 0.7× 391 1.1× 85 0.3× 150 0.6× 73 0.3× 46 1.4k

Countries citing papers authored by Jill Giles‐Komar

Since Specialization
Citations

This map shows the geographic impact of Jill Giles‐Komar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Giles‐Komar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Giles‐Komar more than expected).

Fields of papers citing papers by Jill Giles‐Komar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Giles‐Komar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Giles‐Komar. The network helps show where Jill Giles‐Komar may publish in the future.

Co-authorship network of co-authors of Jill Giles‐Komar

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Giles‐Komar. A scholar is included among the top collaborators of Jill Giles‐Komar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Giles‐Komar. Jill Giles‐Komar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santulli-Marotto, Sandra, et al.. (2015). Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging. PLoS ONE. 10(12). e0145078–e0145078. 16 indexed citations
2.
Harman, Benjamin C., Jill Giles‐Komar, & Michael A. Rycyzyn. (2014). Antibody Discovery from Immune Competent and Immune Transplanted Mice. Current Drug Discovery Technologies. 11(1). 65–73. 3 indexed citations
3.
Hornby, Pamela J., Philip Cooper, John R. Mabus, et al.. (2013). FcRn Expression and Antibody Transcytosis in Adult Human and Non‐Human Primate Intestine. The FASEB Journal. 27(S1). 2 indexed citations
4.
Raju, T. Shantha, et al.. (2012). Solubility evaluation of murine hybridoma antibodies. mAbs. 4(3). 319–325. 38 indexed citations
5.
Cooper, Philip, Robert A. Perkinson, John R. Mabus, et al.. (2012). Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 304(3). G262–G270. 26 indexed citations
6.
Yeilding, Newman, Philippe Szapary, Carrie Brodmerkel, et al.. (2012). Development of the IL‐12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives – an update. Annals of the New York Academy of Sciences. 1263(1). 1–12. 22 indexed citations
7.
Duffy, Karen E., et al.. (2011). Generation and Characterization of Rat Anti-mouse ST2L Monoclonal Antibodies. Hybridoma. 30(2). 153–162. 5 indexed citations
8.
Ekert, Jason E., et al.. (2011). Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. PubMed. 4(1). 23–23. 58 indexed citations
9.
Benson, Jacqueline, David Peritt, Bernard J. Scallon, et al.. (2011). Discovery and mechanism of ustekinumab. mAbs. 3(6). 535–545. 254 indexed citations
10.
Yeilding, Newman, Philippe Szapary, Carrie Brodmerkel, et al.. (2011). Development of the IL‐12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives. Annals of the New York Academy of Sciences. 1222(1). 30–39. 60 indexed citations
11.
Panavas, Tadas, et al.. (2011). Development and Utilization of Activated STAT3 Detection Assays for Screening a Library of Secreted Proteins. Assay and Drug Development Technologies. 9(4). 420–429. 5 indexed citations
12.
Fransson, Johan, A. Teplyakov, G. Raghunathan, et al.. (2010). Human Framework Adaptation of a Mouse Anti-Human IL-13 Antibody. Journal of Molecular Biology. 398(2). 214–231. 29 indexed citations
13.
Rycyzyn, Michael A., et al.. (2008). The Use of an Anti-CD40 Agonist Monoclonal Antibody During Immunizations Enhances Hybridoma Generation. Hybridoma. 27(1). 25–30. 5 indexed citations
14.
Bannish, Gregory, et al.. (2006). A rapid and efficient method for generating anti-variable region monoclonal antibodies using type-1 interferons as immune modulators. Human Antibodies. 15(3). 61–69. 1 indexed citations
15.
Giles‐Komar, Jill, et al.. (2005). High expression of RELP (Reg IV) in neoplastic goblet cells of appendiceal mucinous cystadenoma and pseudomyxoma peritonei. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 448(3). 295–300. 19 indexed citations
16.
Pendley, Charles, et al.. (2005). A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFα antibody in human serum. Journal of Pharmaceutical and Biomedical Analysis. 38(4). 703–708. 7 indexed citations
17.
Yang, Gaoyun, Lily Li, A. Paige Davis Volk, et al.. (2005). Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice. Journal of Pharmacology and Experimental Therapeutics. 313(1). 8–15. 73 indexed citations
18.
Knight, David, Robert E. Jordan, Marian Kruszynski, et al.. (2004). Pharmacodynamic enhancement of the anti-platelet antibody Fab abciximab by site-specific pegylation. Platelets. 15(7). 409–418. 19 indexed citations
19.
Korngold, Robert, Joseph C. Marini, Monica E. de Baca, George J. Murphy, & Jill Giles‐Komar. (2003). Role of tumor necrosis factor-α in graft-versus-host disease and graft-versus-leukemia responses. Biology of Blood and Marrow Transplantation. 9(5). 292–303. 83 indexed citations
20.
Cavacini, Lisa A., et al.. (1992). Effect of immunosuppressive therapy on cytolytic activity of immunodeficient mice: Implications for xenogeneic transplantation. Cellular Immunology. 144(2). 296–310. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryvonne Dueymes Breakdown of academic impact, for papers by Liliane Fossati‐Jimack Breakdown of academic impact, for papers by Eva Emmell Breakdown of academic impact, for papers by Almut Meyer‐Bahlburg Breakdown of academic impact, for papers by Alison M. Gizinski Breakdown of academic impact, for papers by Hirofumi Shoda Breakdown of academic impact, for papers by H. J. Radzun Breakdown of academic impact, for papers by Pojen Chen Breakdown of academic impact, for papers by Jeanine Baisch Breakdown of academic impact, for papers by Yoshinori Katada
Rankless by CCL
2026